Aemetis (NASDAQ:AMTX) Announces Quarterly Earnings Results

Aemetis (NASDAQ:AMTX) issued its quarterly earnings data on Thursday. The specialty chemicals company reported ($0.37) EPS for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.12), Zacks reports. The firm had revenue of $59.19 million for the quarter, compared to analyst estimates of $87.79 million.

Aemetis Price Performance

NASDAQ AMTX traded up $0.34 on Friday, hitting $2.10. The company had a trading volume of 1,324,071 shares, compared to its average volume of 999,169. The company’s fifty day moving average price is $2.45 and its 200-day moving average price is $2.32. The company has a market capitalization of $132.81 million, a PE ratio of -1.30 and a beta of 1.73. Aemetis has a 12-month low of $1.22 and a 12-month high of $4.73.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research note on Wednesday, October 8th. Ascendiant Capital Markets lifted their price objective on shares of Aemetis from $20.00 to $21.00 and gave the company a “buy” rating in a report on Monday, October 6th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $17.33.

Insider Activity

In other news, Director Francis P. Barton sold 26,452 shares of Aemetis stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $2.53, for a total value of $66,923.56. Following the sale, the director owned 208,518 shares in the company, valued at $527,550.54. This trade represents a 11.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 14.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its holdings in Aemetis by 15.3% in the 3rd quarter. Vanguard Group Inc. now owns 2,479,163 shares of the specialty chemicals company’s stock worth $5,578,000 after buying an additional 329,760 shares during the last quarter. Jane Street Group LLC purchased a new position in shares of Aemetis in the second quarter valued at approximately $634,000. Goldman Sachs Group Inc. boosted its stake in shares of Aemetis by 71.9% in the first quarter. Goldman Sachs Group Inc. now owns 218,404 shares of the specialty chemicals company’s stock worth $380,000 after acquiring an additional 91,367 shares during the last quarter. Qube Research & Technologies Ltd acquired a new stake in shares of Aemetis in the second quarter worth approximately $246,000. Finally, Russell Investments Group Ltd. increased its position in shares of Aemetis by 412.9% during the second quarter. Russell Investments Group Ltd. now owns 80,754 shares of the specialty chemicals company’s stock worth $200,000 after purchasing an additional 65,010 shares in the last quarter. 27.02% of the stock is owned by hedge funds and other institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.